At a glance
- Originator Nonindustrial source
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 24 May 2001 No-Development-Reported for Bacterial infections in South Korea (Unknown route)
- 20 Feb 1998 New profile
- 20 Feb 1998 Preclinical development for Bacterial infections in South Korea (Unknown route)